- Fapon Biotech COVID-19 Testing Raw Materials Experimentally Proved to Be Effective on Omicron Variant Detection
(Dongguan, China, 04 February 2020) 2020 has an unusual start-up to the world's biotechnology organizations giving the new coronavirus outbreak. And as a global IVD reagent raw material supplier, Fapon acts promptly to fight against the novel coronavirus by providing pivotal raw materials to the downstream diagnostic companies and taking proactive measures to ensure the safety of Fapon employees, especially for individuals who travel to infected regions during the Chinese New Year holiday. To date, no suspected or confirmed case of the virus has been found among Fapon employees.
Followed through the measures of disease prevention and controls arranged by the Chinese Health Department and the Dubai International Aiport, Fapon International Sales Team had arrived Dubai smoothly and exhibits at the Dubai International Convention & Exhibition Centre for Medlab Middle East. Besides the demonstration of new IVD products to visitors, hygiene measures are also implemented at Fapon’s booth ZA.A40 from 3 to 6 February by wearing medical masks and offering alcohol-based hand sanitizer to visitors.